Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big Pharma And Psychedelic Medicine: Eli Lilly's $3.8 Billion Bet
Human brain developing into extraordinary due to use of natural medicine On July 16, 2026, Eli Lilly announced it would acquire AtaiBeckley for up to $3.8 billion — $2.8 billion up front, with another $1 billion in milestone-linked…
Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)
Company announcement No. 33 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 29, 2026) Copenhagen, Denmark, July 20, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 34 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, July 20, 2026 –…
Biotech deals surge to record as fear of missing out grips big pharma
London/New York | Big pharma groups are snapping up biotechs at a record pace as they race to bolster their drug pipelines, spend windfalls from blockbuster medicines and capitalise on lighter-touch regulation under the Trump administration. The…
No Shame: Big Pharma Using Illegal Immigration Issue to Trick Conservatives Into Dancing for Them
Something that informed my decision as a young man to pursue politics was ' Clear and Present Danger,' the movie where Harrison Ford stands up to almost infinite Washington shenanigans. One of the more memorable lines is when the corrupt POTUS…
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?
The iShares Global Healthcare ETF (IXJ 0.56%) provides broad global sector exposure, while VanEck Pharmaceutical ETF (PPH 0.72%) offers a more concentrated, higher-yielding approach specifically focused on pharmaceutical companies. These funds both…
Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026?
Invesco Pharmaceuticals ETF (PJP 0.30%) offers concentrated U.S. pharma exposure, while iShares Global Healthcare ETF (IXJ 0.56%) provides a more diversified, lower-cost global approach with higher assets under management and dividend yields.
Nifty, Sensex open cautiously; banking, pharma stocks weigh
Benchmark equity indices opened on a cautious note on Tuesday morning, with the Sensex and Nifty50 trading marginally in the green after Monday's losses, as investors weighed mixed global cues and continued to track first-quarter corporate…
Natco Pharma gets USFDA nod for generic cancer drug, shares rise 4% intra-day
Hyderabad-based Indian multinational pharmaceutical and biotechnology company Natco Pharma's shares were in the spotlight on Monday after it received tentative approval from the U.S. Food and Drug Administration (FDA) for Olaparib, 100 mg, and 150…
Royalty Pharma PLC $RPRX Holdings Lowered by AlTi Global Inc.
AlTi Global Inc. trimmed its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 50.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 25,073 shares of the…
NewAmsterdam Pharma (NASDAQ:NAMS) Trading Down 5.6% - Time to Sell?
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report)'s share price was down 5.6% on Monday. The stock traded as low as $30.06 and last traded at $29.9130. Approximately 698,804 shares changed hands during mid-day trading, a decline of…
Urogen Pharma (NASDAQ:URGN) Reaches New 12-Month High - Here's What Happened
Urogen Pharma (NASDAQ:URGN - Get Free Report) shares reached a new 52-week high during trading on Tuesday. The company traded as high as $41.92 and last traded at $41.12, with a volume of 550404 shares traded. The stock had previously closed at…
SEB Asset Management AB Invests $12.97 Million in Royalty Pharma PLC $RPRX
SEB Asset Management AB bought a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought…
California Public Employees Retirement System Cuts Stake in Royalty Pharma PLC $RPRX
California Public Employees Retirement System lowered its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 12.9% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 907,318…
SEB Asset Management AB Takes $17.51 Million Position in BridgeBio Pharma, Inc. $BBIO
SEB Asset Management AB purchased a new position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional…
Receive a Daily briefing on Pharma Industry News
Get Started